Targeting the Cbl-b-Notch1 axis as a novel immunotherapeutic strategy to boost CD8+ T-cell responses
Monticone, Giulia, Huang, Zhi, Csibi, Fred, Leit, Silvana, Ciccone, David, Champhekar, Ameya S, Austin, Jermaine E, Ucar, Deniz A, Hossain, Fokhrul, Ibba, Salome V, Boulares, A Hamid, Carpino, Nicholas, Xu, Keli, Majumder, Samarpan, Osborne, Barbara A, Loh, Christine, Miele, Lucio
Published in Frontiers in immunology (26.08.2022)
Published in Frontiers in immunology (26.08.2022)
Get full text
Journal Article
Mechanisms of the Anti-Tumor Activity of STAT3 Degraders in Lymphoma
Rong, Haojing, Sharma, Kirti, Csibi, Fred, Yang, Bin, Rusin, Scott, Shi, Yatao, Dey, Joyoti, Karnik, Rahul, Mayo, Michele, Yuan, Karen, Chutake, Yogesh, McDonald, Alice, Zhu, Sean, Ji, Nan, Liu, Phillip, Li, Henry, Walker, Duncan, Gollob, Jared, Mainolfi, Nello, Desavi, Chris
Published in Blood (05.11.2020)
Published in Blood (05.11.2020)
Get full text
Journal Article
Small Molecule-Induced, Selective STAT3 Degradation Leads to Anti-Tumor Activity in STAT3-Dependent Heme Malignancies
Csibi, Fred, Ji, Nan, Yang, Bin, Yuan, Karen, Mayo, Michele, Rong, Haojing, Rusin, Scott, Sharma, Kirti, Loh, Christine, Li, Henry, Townson, Sharon, Chen, Jesse, Kamadurai, Hari, Walker, Duncan, Gollob, Jared, Mainolfi, Nello
Published in Blood (13.11.2019)
Published in Blood (13.11.2019)
Get full text
Journal Article
Abstract C054: Discovery of KYM-003, a potent and selective STAT3 degrader with antitumor activity in heme malignancies
Csibi, Fred, Ji, Nan, Yang, Bin, Yuan, Karen, Mayo, Michele, Rong, Haojing, Rusin, Scott, Sharma, Kirti, Loh, Christine, Li, Henry, Townson, Sharon, Kamadurai, Hari, Chen, Jesse, Walker, Duncan, Gollob, Jared, Mainolfi, Nello
Published in Molecular cancer therapeutics (01.12.2019)
Published in Molecular cancer therapeutics (01.12.2019)
Get full text
Journal Article
Abstract 2064: Targeting Cblb-Notch1 axis as a novel strategy for cancer immunotherapy
Monticone, Giulia, Csibi, Fred, Leit, Silvana, Austin, Jermaine E., Ucar, Deniz A., Hossain, Fokhrul M., Majumder, Samarpan, Osborne, Barbara A., Loh, Christine, Miele, Lucio
Published in Cancer research (Chicago, Ill.) (15.06.2022)
Published in Cancer research (Chicago, Ill.) (15.06.2022)
Get full text
Journal Article
Abstract 1185: H3B-8800, a novel orally available SF3b modulator, shows preclinical efficacy across spliceosome mutant cancers
Buonamici, Silvia, Yoshimi, Akihide, Thomas, Michael, Seiler, Michael, Chan, Betty, Caleb, Benjamin, Csibi, Fred, Darman, Rachel, Fekkes, Peter, Karr, Craig, Keaney, Gregg, Kim, Amy, Klimek, Virginia, Kumar, Pavan, Kunii, Kaiko, Lee, Stanley Chun-Wei, Liu, Xiang, MacKenzie, Crystal, Meeske, Carol, Mizui, Yoshiharu, Padron, Eric, Park, Eunice, Pazolli, Ermira, Prajapati, Sudeep, Rioux, Nathalie, Taylor, Justin, Wang, John, Warmuth, Markus, Yao, Huilan, Yu, Lihua, Zhu, Ping, Abdel-Wahab, Omar, Smith, Peter
Published in Cancer research (Chicago, Ill.) (01.07.2017)
Published in Cancer research (Chicago, Ill.) (01.07.2017)
Get full text
Journal Article
Abstract 589: Discovery of NTX-001, a potent Cbl-b inhibitor with antitumor activity in syngeneic models
Csibi-Levin, Fred, Leit, Silvana, Laughton, David L., Baker, Tom, Jacques, Suzanne L., Browning, Beth, Toms, Angela V., Garside, Samantha, D'Archivio, Simon, Kopycka, Katarzyna, Zhu, Xiaohua, Jordan, Allan M., Thomson, Stuart, Loh, Christine, Tummino, Peter, Ciccone, David N.
Published in Cancer research (Chicago, Ill.) (15.06.2022)
Published in Cancer research (Chicago, Ill.) (15.06.2022)
Get full text
Journal Article
Targeting Cblb-Notch1 axis as a novel immunotherapeutic strategy to boost CD8+ T-cells responses
Monticone, Giulia, Csibi, Fred, Leit, Silvana, Ciccone, David, Champhekar, Ameya, Austin, Jermaine E, Ucar, Deniz A, Hossain, Fokhrul, Huang, Zhi, Ibba, Salome V, A Hamid Boulares, Carpino, Nicholas, Majumder, Samarpan, Xu, Keli, Osborne, Barbara A, Loh, Christine, Miele, Lucio
Published in bioRxiv (16.03.2022)
Published in bioRxiv (16.03.2022)
Get full text
Paper